内視鏡的逆行性胆管膵管造影（ERCP）の市場規模、シェア、成長分析：タイプ別、用途別、エンドユーザー別、地域別 - 産業予測、2024-2031年

内視鏡的逆行性胆管膵管造影（ERCP）市場規模は2022年に19億米ドルと評価され、2023年の20億9,000万米ドルから2031年には44億1,000万米ドルに成長し、予測期間（2024-2031年）のCAGRは9.80%で成長する見通しです。

低侵襲手術法の台頭により、内視鏡的逆行性胆管膵管造影（ERCP）手技の需要が増加しており、今後数年間の業界の堅調な成長の舞台となっています。ERCPを選択する患者数が増加しているのは、主に低侵襲アプローチの利点によるもので、従来の外科的手法と比較して、回復時間の短縮と合併症の減少が約束されています。さらに、米国がん協会の2023年1月の年次報告書では、米国で新たに約41,210人の肝臓がん患者が発生すると予測されており、高度な診断および治療ソリューションの緊急要件が強調されています。

目次

イントロダクション

• 調査の目的
• 定義
• 市場範囲

調査手法

• 情報調達
• 二次データソースと一次データソース
• 市場規模予測
• 市場の想定と制限

エグゼクティブサマリー

• 市場概要見通し
• 供給需要動向分析
• セグメント別機会分析

市場力学と見通し

• 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
• ポーターの分析

主な市場の考察

• 技術分析
• バリューチェーン分析
• 価格分析
• スタートアップ分析
• 規制情勢
• 特許分析
• パイプライン分析
• 重要成功要因
• 市場の魅力指数
• 競合の程度
• 主な投資機会
• エコシステムマッピング

内視鏡的逆行性胆管膵管造影（ERCP）市場：タイプ別

• 市場概要
• 内視鏡
• 内視鏡治療デバイス
• イメージングシステム
• エネルギーデバイス
• その他

内視鏡的逆行性胆管膵管造影（ERCP）市場：用途別

• 市場概要
• 胆道括約筋切開術
• 胆管ステント
• 胆管拡張症
• 膵管ステント留置術
• 膵管拡張
• 膵括約筋切開術

内視鏡的逆行性胆管膵管造影（ERCP）市場：エンドユーザー別

• 市場概要
• 病院・クリニック
• 外来手術センター

内視鏡的逆行性胆管膵管造影（ERCP）市場：地域別

• 市場概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ（MEA）
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ地域

競合情勢

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場における最近の活動
• 主要企業の市場シェア（2023年）

主要企業プロファイル

• Olympus Corporation
• CONMED Corporation
• HOYA Corporation
• Fujifilm Holdings Corporation
• KARL STORZ SE & Co. KG
• Ambu A/S
• Johnson & Johnson
• Boston Scientific Corporation
• Medtronic PLC
• Cook Medical
• B. Braun Melsungen AG.

Endoscopic Retrograde Cholangiopancreatography Market size was valued at USD 1.9 billion in 2022 and is poised to grow from USD 2.09 billion in 2023 to USD 4.41 billion by 2031, growing at a CAGR of 9.80% in the forecast period (2024-2031).

The rise of minimally invasive surgical methods has led to an increased demand for endoscopic retrograde cholangiopancreatography (ERCP) procedures, setting the stage for a robust industry growth in the coming years. The growing number of patients opting for ERCP is primarily driven by the benefits of minimally invasive approaches, which promise quicker recovery times and fewer complications compared to traditional surgical techniques. Additionally, the American Cancer Society's January 2023 annual report projects approximately 41,210 new cases of liver cancer in the United States, underscoring the urgent requirement for advanced diagnostic and therapeutic solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Endoscopic Retrograde Cholangiopancreatography market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Endoscopic Retrograde Cholangiopancreatography Market Segmental Analysis

Endoscopic retrograde cholangiopancreatography market is segmented based on product type, application, end user, and region. Based on product type, the market is segmented into endoscopes, endotherapy devices, imaging systems, energy devices, and others. Based on application, the market is segmented into Biliary Sphincterotomy, Biliary Stenting, Biliary Dilatation, Pancreatic Duct Stenting, Pancreatic Duct Dilatation, Pancreatic Sphincterotomy. Based on end user, the market is segmented into hospitals & clinics and ambulatory surgical centers, and others. Based on region, the market is segmented into North America, Europe, APAC, Middle East and Africa, LATAM.

Drivers of the Endoscopic Retrograde Cholangiopancreatography Market

ERCP, short for endoscopic retrograde cholangiopancreatography, is a specialized medical procedure designed for both diagnosing and treating conditions affecting the pancreas, liver, gallbladder, and bile ducts. This diagnostic and therapeutic technique combines luminal endoscopy with fluoroscopy-based imaging, providing a comprehensive approach to addressing pancreatobiliary diseases. The procedure involves using an endoscope-a flexible, elongated, and illuminated tube-alongside X-ray technology. The endoscope is carefully guided through the digestive system to enable direct visualization of the targeted organs and systems. Concurrently, X-ray images are captured to provide detailed information about the pancreas, liver, gallbladder, and bile ducts.

Restraints in the Endoscopic Retrograde Cholangiopancreatography Market

The market's growth is constrained by strict regulatory guidelines imposed by regulatory bodies in various countries, which present challenges for introducing new technologies. Compliance with these regulations requires rigorous testing and adherence to safety and efficacy standards, contributing to a complex and time-consuming approval process for new medical technologies. Despite these regulatory challenges, the market is experiencing some positive impacts. The increase in disposable income, particularly in developing countries, has emerged as a catalyst for market expansion.

Market Trends of the Endoscopic Retrograde Cholangiopancreatography Market

The market is expected to gain substantial momentum from strategic initiatives undertaken by key industry players, such as impactful actions including product launches, mergers, and acquisitions. A notable example is the strategic distribution agreement forged between Olympus and EndoClot Plus in April 2022. EndoClot Plus, a specialist in hemostasis technology, introduced the EndoClot PHS-a nonthermal, nontraumatic method designed for fast and reliable hemostasis in gastrointestinal bleeding. This collaboration highlights the market's commitment to advancing existing solutions in therapeutic endoscopy.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Value Chain Analysis
• Pricing Analysis
• Start Up Analysis
• Regulatory Landscape
• Patent Analysis
• Pipeline Analysis
• Key Success Factors
• Market Attractiveness Index
• Degree of Competition
• Top Investment Pockets
• Ecosystem Mapping

Endoscopic Retrograde Cholangiopancreatography Market by Type

• Market Overview
• Endoscopes
• Endo-therapy Devices
• Imaging Systems
• Energy Devices
• Others

Endoscopic Retrograde Cholangiopancreatography Market by Application

• Market Overview
• Biliary Sphincterotomy
• Biliary Stenting
• Biliary Dilatation
• Pancreatic Duct Stenting
• Pancreatic Duct Dilatation
• Pancreatic Sphincterotomy

Endoscopic Retrograde Cholangiopancreatography Market by End User

• Market Overview
• Hospitals & Clinic
• Ambulatory Surgical Centres

Endoscopic Retrograde Cholangiopancreatography Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Olympus Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CONMED Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HOYA Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KARL STORZ SE & Co. KG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ambu A/S
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments